Trigg, Laura A. http://orcid.org/0000-0002-8447-2616
Barnish, Maxwell S.
Hayward, Samuel
Shaw, Naomi
Crathorne, Louise
Groves, Brad
Spoors, John
Strong, Thomas
Melendez-Torres, G. J.
Farmer, Caroline http://orcid.org/0000-0003-3553-8970
Funding for this research was provided by:
NHS England
Article History
Accepted: 23 November 2023
First Online: 12 December 2023
Declarations
:
: No authors declare any competing interests relevant to the present work.
: This work was supported by NHS England.
: The study was informed by publicly available data found at ExternalRef removed, and included an analysis of managed access agreements of technologies in the Cancer Drugs Fund, and their corresponding data collection agreements.
: The project was approved by the University of Exeter College of Medicine and Health Research Ethics committee (ref: 20/11/264).
: CF, BG and JS designed the research. NS identified all relevant source materials. LT, SH, LC and M.B contributed to the data extraction. GMT, CF and LT carried out the data analysis for the uncertainties, and LT carried out the data analysis for the data collection agreements. CF designed the data collection tools, quality assured the data extraction and is the guarantor for this manuscript. LT drafted the manuscript with all authors contributing to the revision. The authors acknowledge the administrative support provided by Mrs Sue Whiffin and Ms Jenny Lowe.
: Not applicable.
: Not applicable.
: Not applicable. Data available upon request.